blog.aids.gov − Search Results blog.aids.gov − National Institute of Neurological Disorders and Stroke”
AIDS.GOV | SERVICE LOCATOR | SEARCH

BLOG.AIDS.GOV

MENU

Search Results for: National Institute of Neurological Disorders and Stroke"

NIH Expands Investment in HIV Cure Research

Logo for National Institute of Allergy and Infectious Disease

Six Research Teams to Lead Collaborative Investigations Worldwide The National Institutes of Health has awarded approximately $30 million in annual funding over the next five years to six research collaborations working to advance basic medical science toward an HIV cure. The awards comprise the second iteration of the Martin Delaney Collaboratory: Towards an HIV-1 Cure…

National HIV/AIDS and Aging Awareness Day: A Perspective from the National Institutes of Health

blog.aids.gov

Co-authored by Scott Proestel, M.D., Division of AIDS, National Institute of Allergy and Infectious Diseases, NIH

On September 18, 2011, we mark the fourth observance of National HIV/AIDS and Aging Awareness Day. The remarkable success of antiretroviral therapies in prolonging the lives of HIV-infected individuals who have access to and can tolerate these drugs has

Biomarker Tracks Accelerated HIV-Associated Aging

NIH logo - cropped - April 2016

Infection Adds Five Years on Average to Biological Age By measuring a molecular signature of aging, researchers have found that HIV infection accelerates aging, adding an average of five years to someone’s biological age. The more rapid aging is occurring in people receiving antiretroviral treatment, so that even though treatment enables them to live for…

Early Antiretroviral Therapy Prevents Non-Aids Outcomes in HIV-Infected People, NIH-Supported Study Finds

NIH logo

New Findings Illustrate Manifold Benefit of Therapy Starting antiretroviral therapy early not only prevents serious AIDS-related diseases, but also prevents the onset of cancer, cardiovascular disease, and other non-AIDS-related diseases in HIV-infected people, according to a new analysis of data from the Strategic Timing of AntiRetroviral Treatment (START) study, the first large-scale randomized clinical trial to…

Starting antiretroviral treatment early improves outcomes for HIV-infected individuals

nih logo

For Immediate Release: Wednesday, May 27, 2015 NIH-funded trial results likely will impact global treatment guidelines A major international randomized clinical trial has found that HIV-infected individuals have a considerably lower risk of developing AIDS or other serious illnesses if they start taking antiretroviral drugs sooner, when their CD4+ T-cell count—a key measure of immune…